RCKT (Rocket Pharmaceuticals) Interest Received


RCKT Rocket Pharmaceuticals Inc RCKT
21 GF Score
Price $3.91
! 3 Warning Signs
View Full Analysis

What is Rocket Pharmaceuticals Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

RCKT
21GF Score
Rocket Pharmaceuticals Inc RCKT
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rocket Pharmaceuticals Business Description

Other Exchanges 9IP1:Germany
Address 9 Cedarbrook Drive, Cranbury, NJ, USA, 08512
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
21GF Score

Get the complete analysis for RCKT

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.91
Price